JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apparsundaram, S.
Right arrow Articles by Blakely, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apparsundaram, S.
Right arrow Articles by Blakely, R. D.

Vol. 287, Issue 2, 733-743, November 1998

Acute Regulation of Norepinephrine Transport: I. Protein Kinase C-Linked Muscarinic Receptors Influence Transport Capacity and Transporter Density in SK-N-SH Cells1

Subramaniam Apparsundaram, Aurelio Galli, Louis J. DeFelice, H. Criss Hartzell and Randy D. Blakely

Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University School of Medicine, Nashville, Tennessee (S.A., A.G., L.J.D., R.D.B.) and Department of Anatomy and Cell Biology, Emory University School of Medicine, Atlanta, Georgia (H.C.H.)

Using SK-N-SH cells, we observe that muscarinic acetylcholine receptor activation by methacholine (MCh) rapidly and selectively diminishes l-NE transport capacity (Vmax) with little or no change in norepinephrine (NE) Km and without apparent effects on membrane potential monitored directly under current clamp. Over the same time frame, MCh exposure reduces the density of [3H]nisoxetine binding sites (Bmax) in intact cells but not in total membrane fractions, consistent with a loss of transport capacity mediated by sequestration of transporters rather than changes in intrinsic transport activity or protein degradation. Similar changes in NE transport and [3H]nisoxetine binding capacity are observed after phorbol ester (beta -PMA) treatment. Inhibition of PKC by antagonists and downregulation of PKC by chronic treatment with phorbol esters abolishes beta -PMA-mediated effects but produce only a partial blockade of MCh-induced effects. Neither muscarinic acetylcholine receptor nor PKC activation require extracellular Ca++ to diminish NET activity. In contrast, treatment of cells with the Ca++/ATPase antagonist, thapsigargin in Ca++-free medium, eliminates the staurosporine-insensitive component of MCh regulation. These findings were further corroborated by the ability of [1,2-bis(o-amino-phenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl)ester application in Ca++-free medium to abolish NET regulation by MCh. Although they may contribute to basal NET expression, we could not implicate CaMKII-, PKA- or nitric oxide-linked pathways in MCh regulation. Together, these findings 1) provide evidence in support of G-protein coupled receptor-mediated regulation of catecholamine transport, 2) reveal intracellular Ca++-sensitive, PKC-dependent and -independent pathways that serve to regulate NET expression and 3) indicate that the diminished capacity for NE transport evident after mAChR and PKC activation involves a redistribution of NET protein.


0022-3565/98/2872-0733$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. S. Mazei-Robison, E. Bowton, M. Holy, M. Schmudermaier, M. Freissmuth, H. H. Sitte, A. Galli, and R. D. Blakely
Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant
J. Neurosci., July 9, 2008; 28(28): 7040 - 7046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. A. Paczkowski, I. A. Sharpe, S. Dutertre, and R. J. Lewis
{chi}-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model
J. Biol. Chem., June 15, 2007; 282(24): 17837 - 17844.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Jayanthi, B. Annamalai, D. J. Samuvel, U. Gether, and S. Ramamoorthy
Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization
J. Biol. Chem., August 18, 2006; 281(33): 23326 - 23340.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs
Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts
Hypertension, February 1, 2006; 47(2): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
R. D. Blakely, L. J. DeFelice, and A. Galli
Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them
Physiology, August 1, 2005; 20(4): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Vaughan
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Jayanthi, D. J. Samuvel, and S. Ramamoorthy
Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters: EVIDENCE FOR LOCALIZATION IN LIPID RAFTS AND LIPID RAFT-MEDIATED INTERNALIZATION
J. Biol. Chem., April 30, 2004; 279(18): 19315 - 19326.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. K. Hahn, D. Robertson, and R. D. Blakely
A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters
J. Neurosci., June 1, 2003; 23(11): 4470 - 4478.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T.-A. Ansah, S. Ramamoorthy, S. Montanez, L. C. Daws, and R. D. Blakely
Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the {alpha}2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 956 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
U. Sung, S. Apparsundaram, A. Galli, K. M. Kahlig, V. Savchenko, S. Schroeter, M. W. Quick, and R. D. Blakely
A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity
J. Neurosci., March 1, 2003; 23(5): 1697 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Granas, J. Ferrer, C. J. Loland, J. A. Javitch, and U. Gether
N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization
J. Biol. Chem., February 7, 2003; 278(7): 4990 - 5000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Torres, A. Carneiro, K. Seamans, C. Fiorentini, A. Sweeney, W.-D. Yao, and M. G. Caron
Oligomerization and Trafficking of the Human Dopamine Transporter. MUTATIONAL ANALYSIS IDENTIFIES CRITICAL DOMAINS IMPORTANT FOR THE FUNCTIONAL EXPRESSION OF THE TRANSPORTER
J. Biol. Chem., January 17, 2003; 278(4): 2731 - 2739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Foster, B. Pananusorn, and R. A. Vaughan
Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum
J. Biol. Chem., July 5, 2002; 277(28): 25178 - 25186.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Derbez, R. M. Mody, and L. L. Werling
sigma 2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 306 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Apparsundaram, U. Sung, R. D. Price, and R. D. Blakely
Trafficking-Dependent and -Independent Pathways of Neurotransmitter Transporter Regulation Differentially Involving p38 Mitogen-Activated Protein Kinase Revealed in Studies of Insulin Modulation of Norepinephrine Transport in SK-N-SH Cells
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 666 - 677.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Roubert, C. Sagne, M. Kapsimali, P. Vernier, F. Bourrat, and B. Giros
A Na+/Cl--Dependent Transporter for Catecholamines, Identified as a Norepinephrine Transporter, Is Expressed in the Brain of the Teleost Fish Medaka (Oryzias latipes)
Mol. Pharmacol., September 1, 2001; 60(3): 462 - 473.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. D. Mayfield and N. R. Zahniser
Dopamine D2 Receptor Regulation of the Dopamine Transporter Expressed in Xenopus laevis Oocytes Is Voltage-Independent
Mol. Pharmacol., January 1, 2001; 59(1): 113 - 121.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. L. Bauman, S. Apparsundaram, S. Ramamoorthy, B. E. Wadzinski, R. A. Vaughan, and R. D. Blakely
Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A
J. Neurosci., October 15, 2000; 20(20): 7571 - 7578.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
M. L. Beckman and M. W. Quick
The Ups and Downs of Neurotransmitter Transporters
Neuroscientist, June 1, 2000; 6(3): 199 - 207.
[Abstract] [PDF]


Home page
NEJMHome page
J. R. Shannon, N. L. Flattem, J. Jordan, G. Jacob, B. K. Black, I. Biaggioni, R. D. Blakely, and D. Robertson
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
N. Engl. J. Med., February 24, 2000; 342(8): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Daniels and S. G. Amara
Regulated Trafficking of the Human Dopamine Transporter. CLATHRIN-MEDIATED INTERNALIZATION AND LYSOSOMAL DEGRADATION IN RESPONSE TO PHORBOL ESTERS
J. Biol. Chem., December 10, 1999; 274(50): 35794 - 35801.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. E. Melikian and K. M. Buckley
Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter
J. Neurosci., September 15, 1999; 19(18): 7699 - 7710.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Saunders, J. V. Ferrer, L. Shi, J. Chen, G. Merrill, M. E. Lamb, L. M. F. Leeb-Lundberg, L. Carvelli, J. A. Javitch, and A. Galli
Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
PNAS, June 6, 2000; 97(12): 6850 - 6855.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. L. Beckman, E. M. Bernstein, and M. W. Quick
Multiple G Protein-Coupled Receptors Initiate Protein Kinase C Redistribution of GABA Transporters in Hippocampal Neurons
J. Neurosci., June 1, 1999; 19(11): RC9 - RC9.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.